ABIONYX Pharma SA (ABNX.PA) Stock Price

€3.95 0%

Disclaimer
TrendEdge.ai is a data analytics platform. Our AI Scores, forecasts, and alerts are generated from models and alternative data sources. They are for informational and educational purposes only and should not be relied upon as investment advice. We do not make personal recommendations. Past performance is not a reliable indicator of future results. Investing involves risk, including loss of capital.

AI Score

Alternative

10
Fundamental

8
Technical

8

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on ABIONYX Pharma SA, AI stock picks, stock alerts and much more.

ABNX.PA AI Stock Analysis

AI stock analysis for ABNX.PA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like ABIONYX Pharma SA (ABNX.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

ABIONYX Pharma SA (ABNX.PA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of ABIONYX Pharma SA (ABNX.PA), currently trading at €3.95, will... Sign up to access price prediction.

About ABNX.PA

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.
Symbol

ABNX.PA
Market

EURONEXT
Industry

Biotechnology
Market Cap

137M

Similar Stocks

Valneva SE VLA.PA	€3.8 2.2%	5
Financière de Tubize SA TUB.BR	€169.2 0.5%	8
OSE Immunotherapeutics SA OSE.PA	€5.91 1.9%	5
UCB SA UCB.BR	€207.4 1.1%	6
Innate Pharma S.A. IPH.PA	€1.72 2.6%	5

News

No news articles.

ABNX.PA Alternative Data

Web Traffic

ABIONYX Pharma SA receives an estimated 8892 monthly visitors to abionyx.com, which is up by 681.4% over the last month.

Web Traffic

8892
Change from Previous Month

681.4%
3 Month Change

911.6%
YoY Change

911.6%

Twitter Followers

ABIONYX Pharma SA has 269 Twitter Followers on its main Twitter (also known as X) account, which is up by 6.7% over the last month.

Twitter Followers

269
Daily Change

0.4%
1 Month Change

6.7%
3 Month Change

11.2%
YoY Change

11.2%

Job Postings

ABIONYX Pharma SA currenly has an estimated 0 open job postings.

Job Postings

0
Daily Change

0%
1 Month Change

0%
3 Month Change

0%
YoY Change

0%

Reddit Mentions

ABIONYX Pharma SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

Reddit Mentions

0
Daily Change

0%
1 Month Change

0%
3 Month Change

0%

LinkedIn Followers

1,586 are following ABIONYX Pharma SA on LinkedIn, up by 2.6% over the last month.

LinkedIn Followers

1586
Daily Change

2.6%
1 Month Change

2.6%
3 Month Change

5.8%
YoY Change

5.8%

LinkedIn Employees

According to LinkedIn, ABIONYX Pharma SA has 9 employees, up by 12.5% over the last month.

LinkedIn Employees

9
Daily Change

12.5%
1 Month Change

12.5%
3 Month Change

12.5%
YoY Change

12.5%

News Mentions

ABIONYX Pharma SA was mentioned 0 times in the news yesterday.

News Mentions

0
Daily Change

0%
1 Month Change

0%
3 Month Change

0%
YoY Change

0%

ABNX.PA Financials

ABNX.PA Key Metrics

Total Revenue

€2.3M
Net Income

-€2.3M
Earnings per Share

-€0.072
Free cash flow

-€1.7M
EBITDA

€2.1M
EBITDA Ratio

0.909131
Total Assets

€13.5M

ABNX.PA 2-year Revenue & Income

ABNX.PA 2-year Free Cash Flow

ABNX.PA Technicals

ABNX.PA SMA

ABNX.PA RSI

FAQ

What's the current price of ABIONYX Pharma SA (ABNX.PA) Stock?
The price of an ABIONYX Pharma SA (ABNX.PA) share is €3.95.

What's the market cap of ABIONYX Pharma SA?
The current market cap of ABIONYX Pharma SA is 137M.

What are some stocks similar to ABIONYX Pharma SA (ABNX.PA) that investors often compare it to?
ABIONYX Pharma SA (ABNX.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..

What is the forecast for ABIONYX Pharma SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast ABIONYX Pharma SA's stock price to be around €4.53 in 2026. Starting from the current price of €3.95, this represents a 14.7% change in price, indicating a bullish outlook for the stock.

How to buy ABIONYX Pharma SA (ABNX.PA) Stock?
ABIONYX Pharma SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy ABIONYX Pharma SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.